Macrolides use and the risk of sudden cardiac death

被引:6
作者
Li, Xiang [1 ]
Wang, Min [2 ]
Liu, Guiyang [1 ]
Zhou, Liang [1 ]
Wang, Zhe [1 ]
Li, Chuntong [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Pharm, 51 Fucheng Rd, Beijing 100048, Peoples R China
[2] Gen Hosp PLA Army, Clin Dept 263, Beijing, Peoples R China
关键词
Macrolides; sudden cardiac death; arrhythmia; coronary heart disease; torsades de pointes; SHORT-TERM CLARITHROMYCIN; TRACT INFECTIONS ANALYSIS; CORONARY-ARTERY-DISEASE; TORSADE-DE-POINTES; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; HEART-DISEASE; AZITHROMYCIN; ANTIBIOTICS; ERYTHROMYCIN;
D O I
10.1080/14787210.2016.1179580
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:535 / 537
页数:3
相关论文
共 33 条
  • [21] Chlamydia pneumoniae eradication from carotid plaques.: Results of an open, randomised treatment study
    Melissano, G
    Blasi, F
    Esposito, G
    Tarsia, P
    Dordoni, L
    Arosio, C
    Tshomba, Y
    Fagetti, L
    Allegra, L
    Chiesa, R
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1999, 18 (04) : 355 - 359
  • [22] Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarizations and Torsade de Pointes
    Milberg, P
    Eckardt, L
    Bruns, HJ
    Biertz, J
    Ramtin, S
    Reinsch, N
    Fleischer, D
    Kirchhof, P
    Fabritz, L
    Breithardt, G
    Haverkamp, W
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (01) : 218 - 225
  • [23] Cardiovascular Risks with Azithromycin and Other Antibacterial Drugs
    Mosholder, Andrew D.
    Mathew, Justin
    Alexander, John J.
    Smith, Harry
    Nambiar, Sumathi
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (18) : 1665 - 1668
  • [24] Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
    Rao, Gowtham A.
    Mann, Joshua R.
    Shoaibi, Azza
    Bennett, Charles Lee
    Nahhas, Georges
    Sutton, S. Scott
    Jacob, Sony
    Strayer, Scott M.
    [J]. ANNALS OF FAMILY MEDICINE, 2014, 12 (02) : 121 - 127
  • [25] Oral erythromycin and the risk of sudden death from cardiac causes
    Ray, WA
    Murray, KT
    Meredith, S
    Narasimhulu, SS
    Hall, K
    Stein, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) : 1089 - 1096
  • [26] Ray WA, 2013, NEW ENGL J MED, V368, P1704
  • [27] Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies
    Schembri, Stuart
    Williamson, Peter A.
    Short, Philip M.
    Singanayagam, Aran
    Akram, Ahsan
    Taylor, Joanne
    Singanayagam, Anika
    Hill, Adam T.
    Chalmers, James D.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [28] Concomitant risk factors in reports of Torsades de Pointes associated with macrolide use: Review of the United States Food and Drug Administration Adverse Event Reporting System
    Shaffer, D
    Singer, S
    Korvick, J
    Honig, P
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (02) : 197 - 200
  • [29] CARDIOVASCULAR EVENTS FOLLOWING CLARITHROMYCIN USE IN LOWER RESPIRATORY TRACT INFECTIONS: ANALYSIS OF TWO PROSPECTIVE COHORT STUDIES
    Singanayagam, A.
    Short, P.
    Williamson, P.
    Akram, A.
    Fleming, G.
    Taylor, J.
    Higgins, S.
    Mills, D.
    Singanayagam, A.
    Archibald, R.
    Peet, L.
    Hill, A. T.
    Chalmers, J. D.
    Schembri, S.
    [J]. THORAX, 2012, 67 : A15 - A16
  • [30] Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
    Svanstrom, Henrik
    Pasternak, Bjorn
    Hviid, Anders
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349